Kevin P. Charpentier

1.4k total citations
47 papers, 946 citations indexed

About

Kevin P. Charpentier is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin P. Charpentier has authored 47 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin P. Charpentier's work include Pancreatic and Hepatic Oncology Research (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Organ Donation and Transplantation (5 papers). Kevin P. Charpentier is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Organ Donation and Transplantation (5 papers). Kevin P. Charpentier collaborates with scholars based in United States, France and Netherlands. Kevin P. Charpentier's co-authors include Damian E. Dupuy, Farrah J. Wolf, Murray B. Resnick, Lelia Noble, Devin C. Koestler, Richard Meier, Dominique S. Michaud, Mei Chung, Erika del Castillo and Jacques Izard and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Kevin P. Charpentier

47 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin P. Charpentier United States 16 345 277 249 202 200 47 946
Bart Geboers Netherlands 18 356 1.0× 476 1.7× 161 0.6× 93 0.5× 221 1.1× 38 1.1k
R. Girelli Italy 21 943 2.7× 183 0.7× 486 2.0× 77 0.4× 401 2.0× 55 1.3k
José Yrizarry United States 17 208 0.6× 352 1.3× 458 1.8× 45 0.2× 198 1.0× 33 980
Petrousjka van den Tol Netherlands 12 139 0.4× 270 1.0× 175 0.7× 38 0.2× 79 0.4× 23 767
Rudolph A. Bedford United States 13 459 1.3× 112 0.4× 422 1.7× 103 0.5× 362 1.8× 16 1.1k
Masaaki Kondo Japan 24 318 0.9× 79 0.3× 434 1.7× 328 1.6× 237 1.2× 91 1.6k
Qiyu Zhao China 15 113 0.3× 63 0.2× 135 0.5× 89 0.4× 105 0.5× 59 593
Yoshitaro Shindo Japan 19 552 1.6× 32 0.1× 248 1.0× 263 1.3× 191 1.0× 94 1.0k
Ibrahim Edhemović Slovenia 17 526 1.5× 566 2.0× 414 1.7× 92 0.5× 117 0.6× 29 1.3k
Tomokazu Kusano Japan 11 211 0.6× 36 0.1× 427 1.7× 96 0.5× 225 1.1× 58 786

Countries citing papers authored by Kevin P. Charpentier

Since Specialization
Citations

This map shows the geographic impact of Kevin P. Charpentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Charpentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Charpentier more than expected).

Fields of papers citing papers by Kevin P. Charpentier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Charpentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Charpentier. The network helps show where Kevin P. Charpentier may publish in the future.

Co-authorship network of co-authors of Kevin P. Charpentier

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Charpentier. A scholar is included among the top collaborators of Kevin P. Charpentier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Charpentier. Kevin P. Charpentier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Mei, Naisi Zhao, Richard Meier, et al.. (2021). Comparisons of oral, intestinal, and pancreatic bacterial microbiomes in patients with pancreatic cancer and other gastrointestinal diseases. Journal of Oral Microbiology. 13(1). 1887680–1887680. 28 indexed citations
2.
Raufi, Alexander G., K.L. Leonard, Kevin P. Charpentier, et al.. (2020). Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer. American Journal of Clinical Oncology. 43(12). 857–860. 5 indexed citations
3.
Castillo, Erika del, Richard Meier, Mei Chung, et al.. (2018). The Microbiomes of Pancreatic and Duodenum Tissue Overlap and Are Highly Subject Specific but Differ between Pancreatic Cancer and Noncancer Subjects. Cancer Epidemiology Biomarkers & Prevention. 28(2). 370–383. 146 indexed citations
4.
Charpentier, Kevin P., et al.. (2017). A comparison of outcomes between open, laparoscopic and robotic pancreaticoduodenectomy. HPB. 19. S77–S77. 2 indexed citations
5.
Charpentier, Kevin P., et al.. (2017). A comparison of outcomes between open, laparoscopic and robotic pancreaticoduodenectomy. HPB. 20(4). 364–369. 64 indexed citations
6.
7.
Jackson, Melissa, et al.. (2015). Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique. Journal of Clinical and Translational Hepatology. 3(4). 246–253. 7 indexed citations
8.
Harrington, David, et al.. (2015). What Shape is Your Resident in? Using a Radar Plot to Guide a Milestone Clinical Competency Discussion. Journal of surgical education. 72(6). e294–e298. 7 indexed citations
9.
10.
Morrissey, Paul, et al.. (2011). Performance assessment of surgical residents in a vascular anastomosis laboratory. Journal of the American College of Surgeons. 213(3). S128–S129. 1 indexed citations
11.
Charpentier, Kevin P., et al.. (2011). Irreversible electroporation of the liver and liver hilum in swine. HPB. 13(3). 168–173. 133 indexed citations
12.
Tempero, Margaret A., K.A De Winter, Sanjay Kakar, et al.. (2011). S100A2 as a prognostic marker in patients receiving adjuvant therapy for pancreatic cancer (PC): A secondary analysis of RTOG 9704.. Journal of Clinical Oncology. 29(15_suppl). 4118–4118. 3 indexed citations
13.
Charpentier, Kevin P., et al.. (2010). Irreversible electroporation of the pancreas in swine: a pilot study. HPB. 12(5). 348–351. 93 indexed citations
14.
Brown, Matthew, et al.. (2009). Transplantation of a unilateral fused kidney with inferior ectopia: revascularization utilizing donor aorta and vena cava.. PubMed. 72(10). 585–8. 3 indexed citations
15.
Charpentier, Kevin P., et al.. (2008). Intention to treat survival following liver transplantation for hepatocellular carcinoma within a donor service area. HPB. 10(6). 412–415. 8 indexed citations
16.
Charpentier, Kevin P. & Arun Mavanur. (2008). Removing patients from the liver transplant wait list: A survey of US liver transplant programs. Liver Transplantation. 14(3). 303–307. 16 indexed citations
17.
Yango, Angelito, Reginald Gohh, Paul Morrissey, et al.. (2008). The utility of 6-month protocol renal biopsy under modern immunosuppression. Clinical Nephrology. 70(12). 490–495. 10 indexed citations
18.
Charpentier, Kevin P., Teresa A. Brentnall, Mary P. Bronner, David R. Byrd, & Christopher L. Marsh. (2004). A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clinical Transplantation. 18(1). 105–107. 23 indexed citations
19.
Friedrich, Jeffrey B., Kevin P. Charpentier, Christopher L. Marsh, et al.. (2004). Outcomes with the selective use of enteric exocrine drainage in pancreas transplantation. Transplantation Proceedings. 36(10). 3101–3104. 9 indexed citations
20.
Vater, Youri, et al.. (2003). Unexpected surgical difficulties leading to hemorrhage and gas embolus during laparoscopic donor nephrectomy: a case report. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 50(9). 891–894. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bart Geboers Breakdown of academic impact, for papers by R. Girelli Breakdown of academic impact, for papers by José Yrizarry Breakdown of academic impact, for papers by Petrousjka van den Tol Breakdown of academic impact, for papers by Rudolph A. Bedford Breakdown of academic impact, for papers by Masaaki Kondo Breakdown of academic impact, for papers by Qiyu Zhao Breakdown of academic impact, for papers by Yoshitaro Shindo Breakdown of academic impact, for papers by Ibrahim Edhemović Breakdown of academic impact, for papers by Tomokazu Kusano
Rankless by CCL
2026